The manufacturer announced it has achieved self-affirmed GRAS (Generally Recognized as Safe) status for GanedenBC30 (Bacillus coagulans GBI- 30, 6086).
The company claims an independent panel of scientists conducted an evaluation of research studies and toxicology data on the ingredient.
The probiotic market has grown exponentially in the past few years in the US and is predicted to still have significant room to grow for those companies who can effectively communicate the benefits of the ingredient to consumers.
The concept of friendly bacteria first gained foothold in Europe and has slowly made its way over to the US where, according to Euromonitor data, the probiotic spoonable yoghurt market alone went from $112m in 2001 to $294m in 2006.
"With so many health benefits and potential applications available for GanedenBC30, licensing partners now have one more level of confidence in the safety of GanedenBC30 as an ingredient," said Ganeden's founder and chief scientist, Sean Farmer.
GanedenBC30 is currently used in dietary supplements, as well as animal health products, feminine hygiene and topical applications.
According to the manufacturer, the advantage of this ingredient over others is that it is particularly resistant, exhibits better stability, and as such offers more flexibility in manufacturing and delivery systems.
Ganaden claims GanedenBC30 does not require refrigeration and can survive gastric acidity.
"GanedenBC30 is different from other traditional bacteria because it is surrounded by a natural organic layer that serves as a protective shield against the manufacturing process, shelf life and stomach acids and intestinal bile," said Farmer.
"Because of this unique make-up, GanedenBC30 survives the hostile environment of the stomach, colonizes the intestines, and produces lactic acid, which are all critical factors to the success of a probiotic."